Viemed Healthcare (NASDAQ: VMD) is one of 27 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it compare to its peers? We will compare Viemed Healthcare to related companies based on the strength of its analyst recommendations, dividends, valuation, profitability, earnings, risk and institutional ownership.
Valuation and Earnings
This table compares Viemed Healthcare and its peers gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Viemed Healthcare||$131.31 million||$31.53 million||9.49|
|Viemed Healthcare Competitors||$1.94 billion||$96.17 million||41.79|
This table compares Viemed Healthcare and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Viemed Healthcare Competitors||-39.15%||16.05%||-9.95%|
This is a summary of current recommendations for Viemed Healthcare and its peers, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Viemed Healthcare Competitors||92||389||536||15||2.46|
Viemed Healthcare presently has a consensus price target of $12.50, indicating a potential upside of 68.92%. As a group, “Miscellaneous health & allied services, not elsewhere classified” companies have a potential upside of 4.41%. Given Viemed Healthcare’s stronger consensus rating and higher possible upside, equities analysts plainly believe Viemed Healthcare is more favorable than its peers.
Volatility and Risk
Viemed Healthcare has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500. Comparatively, Viemed Healthcare’s peers have a beta of 7.02, indicating that their average stock price is 602% more volatile than the S&P 500.
Insider & Institutional Ownership
51.1% of Viemed Healthcare shares are held by institutional investors. Comparatively, 44.3% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by institutional investors. 15.2% of Viemed Healthcare shares are held by company insiders. Comparatively, 25.5% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Viemed Healthcare beats its peers on 7 of the 13 factors compared.
Viemed Healthcare Company Profile
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.